Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity

  • Mengle Shao
  • , Chelsea Hepler
  • , Qianbin Zhang
  • , Bo Shan
  • , Lavanya Vishvanath
  • , Gervaise H. Henry
  • , Shangang Zhao
  • , Yu A. An
  • , Yibo Wu
  • , Douglas W. Strand
  • , Rana K. Gupta

Research output: Contribution to journalArticlepeer-review

Abstract

How adipocyte precursor cells are regulated to control depot-specific adipose tissue expansion in obesity remains unclear. Here, Shao et al. identify a HIFα-dependent regulatory mechanism controlling adipocyte progenitor activity in mice and demonstrate the ability of the anti-cancer drug Imatinib to promote metabolically beneficial adipogenesis in obesity.

Original languageEnglish (US)
Pages (from-to)685-701.e7
JournalCell Stem Cell
Volume28
Issue number4
DOIs
StatePublished - Apr 1 2021

Keywords

  • Adipocyte precursor cell
  • Adipogenesis
  • Fibrosis
  • HIF1α
  • Imatinib
  • PDGFR
  • PPARγ

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Fingerprint

Dive into the research topics of 'Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity'. Together they form a unique fingerprint.

Cite this